Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
IPO Date: November 9, 1984
Sector: Healthcare
Industry: Biotech
Market Cap: $353.31M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.19 | 3.59%
Avg Daily Range (30 D): $0.12 | 1.72%
Avg Daily Range (90 D): $0.16 | 2.59%
Institutional Daily Volume
Avg Daily Volume: .75M
Avg Daily Volume (30 D): .59M
Avg Daily Volume (90 D): 1.23M
Trade Size
Avg Trade Size (Sh.): 218
Avg Trade Size (Sh.) (30 D): 88
Avg Trade Size (Sh.) (90 D): 117
Institutional Trades
Total Inst.Trades: 392
Avg Inst. Trade: $1.43M
Avg Inst. Trade (30 D): $.64M
Avg Inst. Trade (90 D): $1.72M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.78M
Avg Closing Trade (30 D): $.64M
Avg Closing Trade (90 D): $2.3M
Avg Closing Volume: 44.2K
   
News
Sep 2, 2025 @ 8:59 AM
Trends & Growth Strategies in the $13.5 Billion Ca...
Source: Researchandmarkets.Com
Aug 12, 2025 @ 2:00 PM
AscellaHealth Ranks No. 535 on the 2025 Inc. 5000 ...
Source: Dea Belazi
May 14, 2025 @ 5:57 PM
US FDA Orphan Drug Rare Disease Market Clinical Tr...
Source: Kuick Research
Apr 29, 2025 @ 10:00 AM
U.S. FDA Approves ZEVASKYNâ„¢ (prademagene zam...
Source: Abeona Therapeutics Inc.
Feb 21, 2025 @ 6:00 PM
Cell and Gene Therapies in Rare Disorders Market t...
Source: Delveinsight
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $2.07 $-.24 $-.14
Diluted EPS $1.71 $-.24 $-.14
Revenue $ .4M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ 108.83M $ -12.03M $ -9.29M
Operating Income / Loss $ -22.79M $ -19.73M $ -16.67M
Cost of Revenue $ $ $
Net Cash Flow $ 147.6M $ -7.42M $ 7.63M
PE Ratio 4.00    
Splits
Jul 05, 2022:   1:25
Oct 24, 2014:   1:50
Jun 05, 2006:   1:5